PUF60

Chr 8AD

poly(U) binding splicing factor 60

Also known as: FIR, RoBPI, SIAHBP1, VRJS

This gene encodes a nucleic acid-binding protein that plays a role in a variety of nuclear processes, including pre-mRNA splicing and transcriptional regulation. The encoded protein forms a complex with the far upstream DNA element (FUSE) and FUSE-binding protein at the myelocytomatosis oncogene (MYC) promoter. This complex represses MYC transcription through the core-TFIIH basal transcription factor. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Aug 2012]

OMIMResearchGenerating clinical summary…
LOFmechanismADLOEUF 0.241 OMIM phenotype
Clinical SummaryPUF60
🧬
Gene-Disease Validity (ClinGen)
syndromic intellectual disability · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
109 unique Pathogenic / Likely Pathogenic· 111 VUS of 296 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Dual constrained — LoF & missense intolerant
LoF Constraint?
0.24LOEUF
pLI 0.997
Z-score 4.33
OE 0.08 (0.030.24)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?
4.44Z-score
OE missense 0.32 (0.280.38)
111 obs / 341.8 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios?
LoF OE?0.08 (0.030.24)
00.351.4
Missense OE?0.32 (0.280.38)
00.61.4
Synonymous OE?1.24
01.21.6
LoF obs/exp: 2 / 25.7Missense obs/exp: 111 / 341.8Syn Z: -2.28
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitivePUF60-related Verheij syndromeLOFAD

This gene — mechanism propensity

DN
0.3296th %ile
GOF
0.4480th %ile
LOF
0.78top 5%

The highest-scoring mechanism for this gene is loss-of-function (haploinsufficiency).

LOFprediction above median · 1 literature citation · 80% of P/LP variants are LoF · LOEUF 0.24 · ClinGen HI: Sufficient evidence for dosage pathogenicity

Literature Evidence

LOFThe distribution of the heterozygous de novo variants (DNV) is shown in context of the genomic structure of PUF60 in Figure 1. Nine of the DNV were predicted to cause loss-of function suggesting haploinsufficiency as the likely mutational mechanism.1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

References

  1. 1.PMID 28327570

ClinVar Variant Classifications

296 submitted variants in ClinVar

Classification Summary

Pathogenic52
Likely Pathogenic57
VUS111
Likely Benign45
Benign6
Conflicting6
52
Pathogenic
57
Likely Pathogenic
111
VUS
45
Likely Benign
6
Benign
6
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
49
3
0
0
52
Likely Pathogenic
38
19
0
0
57
VUS
8
94
8
1
111
Likely Benign
0
10
6
29
45
Benign
0
0
4
2
6
Conflicting
6
Total951261832277

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

65 pathogenic / likely-pathogenic (of 71) ClinVar copy-number / structural variants overlap PUF60 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

PUF60 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →